Congress has moved billions into the munitions and missile industrial base, and the lead times have barely moved. The reason sits upstream of every factory being funded. Solid propellant is a dozen ingredients held in precise balance, and substituting one forces requalification of the propellant, then the motor, then often the missile itself—so the specialty chemical layer beneath the primes never scales. When a single energetics plant in Tennessee exploded last year, three primes lost supply at once. The same pattern governs critical minerals. China’s grip on rare earths rests not on ore but on separation chemistry: the extractants, the equipment, and four decades of process knowledge. America can fund the plants. The molecules are the harder problem.
America must build the molecules it cannot buy.
Ohr pairs biocatalytic selectivity with continuous flow to create strategic molecules from abundant feedstocks rather than refining them out of crude. Selectivity is designed into the reaction instead of recovered downstream, which removes the separation step that made an entire class of compounds uneconomic to produce. Abundant feeds converge on a few privileged structures that fan out into distinct products—shock-insensitive explosives, binders built to spec, high purity rare earth extractants, advanced propulsion hydrocarbons—without redesigning the process for each. The platform is programmable and modular at roughly a ton a day, which makes the manufacturing footprint distributable across allied ground rather than concentrated in one facility an accident can erase.
More Thoughts From the Team at BVVC:
“This sits at the base of several of our focus areas at once, and it is the layer nobody wanted to own. Chemistry is unglamorous. It does not demo. And it is the floor underneath every program the Pentagon is currently trying to buy its way out of trouble on.
We have spent years funding the American energetics rebuild, and the same lesson keeps surfacing: every layer you fix exposes the one beneath it. Modernize the motor and you find the propellant. Modernize the propellant and you find the molecule. Ohr is that last layer. The specialty chemical base beneath it is too thin and too qualification-locked to scale on capital alone, no matter how much of it Congress appropriates.
What makes it investable rather than merely necessary is the order of operations. Ohr did not set out to solve energetics. They built a platform for making molecules the extraction economy structurally cannot reach, then looked at where the absence of those molecules was doing the most damage to the free world. That list is short and it is ours: explosives, binders, rare earth extractants, propulsion. One platform, four chokepoints, each currently a foreign or single-source dependency. We have rarely seen a company where the technical thesis and the geopolitical thesis are the same sentence.
Sovereignty is downstream of manufacturing, and manufacturing is downstream of molecules. Ohr is working on the molecules. That is why we are here.”
“We go back in time to before biology existed, and play evolution again, but this time with a dollar sign on the forehead.”
– Dan Davidi, CEO and Co-Founder